Literature DB >> 35530290

Differential effects of glucose and N-acetylglucosamine on genome instability.

Yuan-Sheng Hsu1,2, Pei-Jung Wu2, Yung-Ming Jeng3, Chun-Mei Hu1,2, Wen-Hwa Lee2,4,5.   

Abstract

Aberrant sugar metabolism is linked to an increased risk of pancreatic cancer. Previously, we found that high glucose induces genome instability and de novo oncogenic KRAS mutation preferentially in pancreatic cells through dysregulation of O-GlcNAcylation. Increasing O-GlcNAcylation by extrinsically supplying N-acetyl-D-glucosamine (GlcNAc) causes genome instability in all kinds of cell types regardless of pancreatic origin. Since many people consume excessive amount of sugar (glucose, fructose, and sucrose) in daily life, whether high sugar consumption directly causes genome instability in animals remains to be elucidated. In this communication, we show that excess sugar in the daily drink increases DNA damage and protein O-GlcNAcylation preferentially in pancreatic tissue but not in other kinds of tissue of mice. The effect of high sugar on the pancreatic tissue may be attributed to the intrinsic ratio of GFAT and PFK activity, a limiting factor that dictates UDP-GlcNAc levels. On the other hand, GlcNAc universally induces DNA damage in all six organs examined. Either inhibiting O-GlcNAcylation or supplementing dNTP pool diminishes the induced DNA damage in these organs, indicating that the mechanism of action is similar to that of high glucose treatment in pancreatic cells. Taken together, these results suggest the potential hazards of high sugar drinks and high glucosamine intake to genomic instability and possibly cancer initiation. AJCR
Copyright © 2022.

Entities:  

Keywords:  DNA damage; GFAT; GlcNAc; Glucose; O-GlcNAcylation; PFK; UDP-GlcNAc; fructose; sucrose

Year:  2022        PMID: 35530290      PMCID: PMC9077085     

Source DB:  PubMed          Journal:  Am J Cancer Res        ISSN: 2156-6976            Impact factor:   5.942


  51 in total

Review 1.  Protein O-GlcNAcylation: emerging mechanisms and functions.

Authors:  Xiaoyong Yang; Kevin Qian
Journal:  Nat Rev Mol Cell Biol       Date:  2017-05-10       Impact factor: 94.444

2.  Genetic evolution of pancreatic cancer: lessons learnt from the pancreatic cancer genome sequencing project.

Authors:  Christine A Iacobuzio-Donahue
Journal:  Gut       Date:  2011-07-11       Impact factor: 23.059

Review 3.  Sugar-sweetened beverages, obesity, type 2 diabetes mellitus, and cardiovascular disease risk.

Authors:  Vasanti S Malik; Barry M Popkin; George A Bray; Jean-Pierre Després; Frank B Hu
Journal:  Circulation       Date:  2010-03-23       Impact factor: 29.690

Review 4.  Glucosamine effects in humans: a review of effects on glucose metabolism, side effects, safety considerations and efficacy.

Authors:  J W Anderson; R J Nicolosi; J F Borzelleca
Journal:  Food Chem Toxicol       Date:  2005-02       Impact factor: 6.023

5.  Glucose-induced beta cell production of IL-1beta contributes to glucotoxicity in human pancreatic islets.

Authors:  Kathrin Maedler; Pavel Sergeev; Frédéric Ris; José Oberholzer; Helen I Joller-Jemelka; Giatgen A Spinas; Nurit Kaiser; Philippe A Halban; Marc Y Donath
Journal:  J Clin Invest       Date:  2002-09       Impact factor: 14.808

6.  Dietary glucosamine under question.

Authors:  Jeremiah E Silbert
Journal:  Glycobiology       Date:  2009-03-02       Impact factor: 4.313

7.  The global, regional, and national burden of pancreatic cancer and its attributable risk factors in 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017.

Authors: 
Journal:  Lancet Gastroenterol Hepatol       Date:  2019-10-21

8.  Inhibition of O-GlcNAcylation protects from Shiga toxin-mediated cell injury and lethality in host.

Authors:  Kyung-Soo Lee; Jieun Lee; Pureum Lee; Bong Chan Jeon; Min Yeong Song; Sojung Kwak; Jungwoon Lee; Jun-Seob Kim; Doo-Jin Kim; Ji Hyung Kim; Vernon L Tesh; Moo-Seung Lee; Sung-Kyun Park
Journal:  EMBO Mol Med       Date:  2021-11-29       Impact factor: 12.137

Review 9.  Role of O-Linked N-Acetylglucosamine Protein Modification in Cellular (Patho)Physiology.

Authors:  John C Chatham; Jianhua Zhang; Adam R Wende
Journal:  Physiol Rev       Date:  2020-07-30       Impact factor: 37.312

10.  Inhibition of GFAT1 in lung cancer cells destabilizes PD-L1 protein.

Authors:  Wenshu Chen; Bryanna Saxton; Mathewos Tessema; Steven A Belinsky
Journal:  Carcinogenesis       Date:  2021-10-05       Impact factor: 4.741

View more
  1 in total

Review 1.  Interplays of glucose metabolism and KRAS mutation in pancreatic ductal adenocarcinoma.

Authors:  Yu-Huei Liu; Chun-Mei Hu; Yuan-Sheng Hsu; Wen-Hwa Lee
Journal:  Cell Death Dis       Date:  2022-09-24       Impact factor: 9.685

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.